Cite

HARVARD Citation

    Zen, M. et al. (2021). Comment on: Prevalence, outcome and management of patients with SLE and secondary antiphospholipid antibody syndrome after aPL seroconversion: reply. Rheumatology. pp. e115-e117. [Online]. 
  
Back to record